Sponsor:
Deepak C. D'Souza
Code:
NCT06671977
Conditions
Major Depression Disorder
Depression
Eligibility Criteria
Sex: All
Age: 21 - 65
Healthy Volunteers: Accepted
Interventions
DMT-Medium Dose
DMT-Low Dose
THC-Medium Dose
THC-Low Dose
Brief summary:
Conditions
Major Depression Disorder
Depression
Study ID
NCT06671977
Start date
Mar 14, 2025
Status verified date
Jun, 2026
Completion date
Dec 1, 2027
Anticipated
Primary completion date
Dec 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 21 - 65
Healthy Volunteers: Accepted
Enrollment
60 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Other
Arms
active comparator: 10 mg slow intravenous push (bolus) over 5 minutes and then 0.01 mg/kg/min for 55 minutes
active comparator: 14 mg slow intravenous push (bolus) over 5 minutes and then 0.015 mg/kg/min for 55 minutes.
active comparator: 0.5 mg over 5 minutes and then 2 mg over and 55 minutes
placebo comparator: Placebo
active comparator: 0.1 mg slow intravenous push (bolus) over 5 minutes and then I mg over 55 minutes
Interventions
DMT-Medium Dose
DMT-Low Dose
THC-Medium Dose
THC-Low Dose
Primary outcome measure
Central contacts
Locations
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine,
Recruiting
West Haven, Connecticut, United States, 06516
Contacts
Sponsor
Deepak C. D'Souza
Last update posted
Jun 16, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Deepak C. D'Souza on 2026-06-16.